AEterna Zentaris Inc. (AEZS)

[BooDog]

Aeterna Zentaris owns the worldwide rights to MacrilenTM.


A new drug application (NDA) to the FDA in AGHD is currently under review with a Prescription Drug Use Fee Act (PDUFA) date of November 5th 2014. MacrilenTM could become the first orally approved product to evaluate AGHD. It is also currently in a Phase 2A investigator-driven trial as a treatment for cancer cachexia.

Not to mention already having the sales team in place and ready to launch on Nov 17th.

http://finance.yahoo.com/news/aeterna-zentaris-announces-formal-implementation-113000632.html

As part of its commercial strategy, Aeterna Zentaris anticipates using approximately 20 full-time sales representatives to cover its assigned U.S. specific territories, while ASCEND will use its existing sales force of over 35 sales representatives to cover its territories. Overall, more than 50 sales representatives are expected to promote both EstroGel® and Macrilen™. Aeterna Zentaris is expected to book all future sales of Macrilen™, while ASCEND will continue to book all sales of EstroGel®.

-----------------------------------------

I know a few are QUITE familiar with how stocks are manipulated going into a PDUFA. Some go ballistic, some don't do a dam thing till after.